BACKGROUND: The assessment of air pollution exposure using only community average concentrations may lead to measurement error that lowers estimates of the health burden attributable to poor air quality. To test this hypothesis, we modeled the association between air pollution and mortality using small-area exposure measures in Los Angeles, California. METHODS: Data on 22,905 subjects were extracted from the American Cancer Society cohort for the period 1982-2000 (5,856 deaths). Pollution exposures were interpolated from 23 fine particle (PM2.5) and 42 ozone (O3) fixed-site monitors. Proximity to expressways was tested as a measure of traffic pollution. We assessed associations in standard and spatial multilevel Cox regression models. RESULTS: After controlling for 44 individual covariates, all-cause mortality had a relative risk (RR) of 1.17 (95% confidence interval=1.05-1.30) for an increase of 10 mug/m PM2.5 and a RR of 1.11 (0.99-1.25) with maximal control for both individual and contextual confounders. The RRs for mortality resulting from ischemic heart disease and lung cancer deaths were elevated, in the range of 1.24-1.6, depending on the model used. These PM results were robust to adjustments for O3 and expressway exposure. CONCLUSION: Our results suggest the chronic health effects associated with within-city gradients in exposure to PM2.5 may be even larger than previously reported across metropolitan areas. We observed effects nearly 3 times greater than in models relying on comparisons between communities. We also found specificity in cause of death, with PM2.5 associated more strongly with ischemic heart disease than with cardiopulmonary or all-cause mortality.
BACKGROUND: The assessment of air pollution exposure using only community average concentrations may lead to measurement error that lowers estimates of the health burden attributable to poor air quality. To test this hypothesis, we modeled the association between air pollution and mortality using small-area exposure measures in Los Angeles, California. METHODS: Data on 22,905 subjects were extracted from the American Cancer Society cohort for the period 1982-2000 (5,856 deaths). Pollution exposures were interpolated from 23 fine particle (PM2.5) and 42 ozone (O3) fixed-site monitors. Proximity to expressways was tested as a measure of traffic pollution. We assessed associations in standard and spatial multilevel Cox regression models. RESULTS: After controlling for 44 individual covariates, all-cause mortality had a relative risk (RR) of 1.17 (95% confidence interval=1.05-1.30) for an increase of 10 mug/m PM2.5 and a RR of 1.11 (0.99-1.25) with maximal control for both individual and contextual confounders. The RRs for mortality resulting from ischemic heart disease and lung cancer deaths were elevated, in the range of 1.24-1.6, depending on the model used. These PM results were robust to adjustments for O3 and expressway exposure. CONCLUSION: Our results suggest the chronic health effects associated with within-city gradients in exposure to PM2.5 may be even larger than previously reported across metropolitan areas. We observed effects nearly 3 times greater than in models relying on comparisons between communities. We also found specificity in cause of death, with PM2.5 associated more strongly with ischemic heart disease than with cardiopulmonary or all-cause mortality.
Authors: Lianne Sheppard; Richard T Burnett; Adam A Szpiro; Sun-Young Kim; Michael Jerrett; C Arden Pope; Bert Brunekreef Journal: Air Qual Atmos Health Date: 2011-03-23 Impact factor: 3.763
Authors: Jaime E Hart; Eric Garshick; Douglas W Dockery; Thomas J Smith; Louise Ryan; Francine Laden Journal: Am J Respir Crit Care Med Date: 2010-07-23 Impact factor: 21.405
Authors: Ketan Shankardass; Michael Jerrett; Joel Milam; Jean Richardson; Kiros Berhane; Rob McConnell Journal: J Epidemiol Community Health Date: 2010-11-11 Impact factor: 3.710
Authors: Grace O Akinlade; Hezekiah B Olaniyi; Felix S Olise; Oyediran K Owoade; Susana M Almeida; Marina Almeida-Silva; Philip K Hopke Journal: Environ Monit Assess Date: 2015-08-01 Impact factor: 2.513
Authors: Chirag J Patel; Jacqueline Kerr; Duncan C Thomas; Bhramar Mukherjee; Beate Ritz; Nilanjan Chatterjee; Marta Jankowska; Juliette Madan; Margaret R Karagas; Kimberly A McAllister; Leah E Mechanic; M Daniele Fallin; Christine Ladd-Acosta; Ian A Blair; Susan L Teitelbaum; Christopher I Amos Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-07-14 Impact factor: 4.254
Authors: Zhaoxi Wang; Yang Liu; Mu Hu; Xiaochuan Pan; Jing Shi; Feng Chen; Kebin He; Petros Koutrakis; David C Christiani Journal: Environ Int Date: 2012-12-07 Impact factor: 9.621